Effect of PNF on Selective Motor Control and Balance in CP

Sponsor
Riphah International University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05649501
Collaborator
(none)
26
1
2
11
2.4

Study Details

Study Description

Brief Summary

Cerebral palsy is attributed to non-progressive disturbances that occurred in the developing infant brain or fetal characterized by abnormalities of muscle tone, movement and motor skills. PNF technique is thought to have an impact on voluntary motor control and balance through stimulation of proprioceptors, so the aim of this study is to determine the effects of proprioceptive neuromuscular facilitation technique on selective motor control and balance on children with cerebral palsy.

Condition or Disease Intervention/Treatment Phase
  • Other: Proprioceptive neuromuscular facilitation techniques.
  • Other: Traditional physical therapy
N/A

Detailed Description

A case study was conducted in 2021 to determine the effects of PNF training for improving lower limb coordination in 7 years old cerebral palsy child. After the intervention, significant improvement is seen in gait parameters, balance, and gross motor functional classification score.

A case report was conducted in 2020, to determine the effectiveness of PNF technique in improving lower extremity function in spastic diplegic cerebral palsied adolescent. Patient was treated with tone inhibitory and movement facilitatory techniques. There was significant change in balance and lower extremity function before and after the treatment.

There are multiple impairments in spastic cerebral palsy children; the inability to perform purposeful voluntary movements is a critical factor in determining functional ability of children. Since selective voluntary motor control is an important factor that must be achieved in cerebral palsy children, PNF may be considered as a technique to gain selective voluntary control and balance proving an important intervention for cerebral palsy children.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
26 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Masking Description:
Randomized
Primary Purpose:
Treatment
Official Title:
Effects of Proprioceptive Neuromuscular Facilitation on Selective Motor Control of Lower Extremity and Balance in Children With Cerebral Palsy
Actual Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Jan 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: proprioceptive neuromuscular facilitation techniques

Experimental group will receive proprioceptive neuromuscular facilitation stretching which include hold-relax and contract-relax for 6 sec hold, 10 repetitions and 2 min rest in between, for 5 day/week for 4 weeks along with conventional physical therapy.

Other: Proprioceptive neuromuscular facilitation techniques.
Proprioceptive neuromuscular facilitation stretching which include hold-relax and contract-relax for 6 sec hold, 10 repetitions and 2 min rest in between, for 5 day/week for 4 weeks along with conventional treatment for 40 minutes.

Active Comparator: traditional physical therapy

this group will receive conventional therapy (ROMs, stretching, strengthening).

Other: Proprioceptive neuromuscular facilitation techniques.
Proprioceptive neuromuscular facilitation stretching which include hold-relax and contract-relax for 6 sec hold, 10 repetitions and 2 min rest in between, for 5 day/week for 4 weeks along with conventional treatment for 40 minutes.

Other: Traditional physical therapy
Conventional therapy (ROMs, stretching, strengthening) of lower limbs for 40 minutes.

Outcome Measures

Primary Outcome Measures

  1. Pediatric Berg Balance Scale [last one week]

    The Pediatric Balance Scale (PBS), a modification of Berg's Balance Scale, was developed as a balance measure for school-age children with mild to moderate motor impairments. It has 14 items with score 0-4. The intra-class correlation coefficient (ICC) is 0.998 (18).

Secondary Outcome Measures

  1. Selective control assessment of lower extremity (SCALE) [last one week]

    The SCALE tool was designed for clinical administration and scoring by healthcare professionals, to be used in less than 15 minutes without specialized equipment. Hip, knee, ankle, subtalar, and toe joints are assessed bilaterally. One representative reciprocal movement that varies from the mass flexor/extensor patterns is chosen to assess SVMC for each joint. Total score is 10 for each limb. Intra-class correlation coefficient ranges from 0.88 to 0.91 (19).

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children diagnosed as spastic diplegic cerebral palsy

  • Age between 5-12 years and both genders.

  • Gross motor function level II and III according to gross motor functional classification scale (GMFCS).

  • Spasticity range between 1 and 1+ grade according to modified ashworth scale

  • Children who are able to follow simple verbal instructions

Exclusion Criteria:
  • Children with uncontrolled epilepsy

  • Children who show no cooperation

  • Children receiving botulinum toxin injections or surgery no earlier than 6 months before project starts.

  • Subjects with presence of shortening or deformities of lower limb

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pakistan Society for Rehabilitation of the Disabled (PSRD) Lahore Punjab Pakistan 54000

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: Shabana Ashraf, Masters, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Riphah International University
ClinicalTrials.gov Identifier:
NCT05649501
Other Study ID Numbers:
  • REC/22/0725 Misbah Tahir
First Posted:
Dec 14, 2022
Last Update Posted:
Jan 25, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Riphah International University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 25, 2023